Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$725.67M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.38 | 3.93%
Avg Daily Range (30 D):	$0.36 | 3.50%
Avg Daily Range (90 D):	$0.38 | 3.68%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	1.05M

Trade Size
Avg Trade Size (Sh.):	104
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	770
Avg Institutional Trade:	$1.49M
Avg Institutional Trade (30 D):	$.89M
Avg Institutional Trade (90 D):	$1.16M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.57M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$1.35M
Avg Closing Volume:	172.03K

News

Feb 24, 2026 @ 12:00 PM Fulcrum Therapeutics Announces Positive 12-Week Re... Source: Na

Dec 12, 2025 @ 2:00 PM Firmware Signing Platform Market Size to Reach USD... Source: Sns Insider

Dec 10, 2025 @ 12:48 PM Fulcrum Therapeutics Announces Pricing of Upsized ... Source: Globe Newswire

Dec 6, 2025 @ 10:30 PM Fulcrum Therapeutics Announces Positive Initial Re... Source: Fulcrum Therapeutics

Nov 19, 2025 @ 1:00 PM Datanomix and Fulcrum Modernize Manufacturing Tech... Source: Greg Mchale And Sunny Han

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-1.18	$-.28	$-.28
Diluted EPS	$-1.18	$-.28	$-.28
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-73.22M	$-17.3M	$-17.66M
Operating Income / Loss	$-84.77M	$-19.82M	$-20.4M
Cost of Revenue
Net Cash Flow	$-44.13M	$-15.62M	$M
PE Ratio